4//SEC Filing
Miller Joseph M 4
Accession 0001628280-23-006531
CIK 0001600620other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:29 PM ET
Size
7.3 KB
Accession
0001628280-23-006531
Insider Transaction Report
Form 4
Miller Joseph M
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-02+229,421→ 342,510 total - Sale
Common Stock
2023-03-02$8.94/sh−11,296$100,986→ 331,214 total
Footnotes (5)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 743 shares of common stock were acquired on May 31, 2022 and 1,656 shares of common stock were acquired on November 30, 2022.
- [F4]The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 229,421 newly awarded RSUs, 104,080 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning March 2, 2022 (Prior RSUs), and 6,610 shares of common stock. On March 2, 2023, 34,693 of Prior RSUs vested and 69,387 of Prior RSUs remained unvested.
- [F5]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001746372
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:29 PM ET
- Size
- 7.3 KB